Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank79
3Y CAGR+169.9%
5Y CAGR+54.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+169.9%/yr
vs -54.4%/yr prior
5Y CAGR
+54.8%/yr
Recent acceleration
Acceleration
+224.3pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
8.9x
Strong expansion
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$27.89M+269.3%
2024$7.55M+22.8%
2023$6.15M+333.6%
2022$1.42M-98.0%
2021$70.41M+2145.1%
2020$3.14M-97.7%
2019$135.39M+313.4%
2018$32.75M+68.8%
2017$19.41M+938.9%
2016$1.87M-